CD56 expression in multiple myeloma: Correlation with poor prognostic markers but no effect on outcome

CD56 or neural cell adhesion molecule (NCAM) is a membrane glycoprotein expressed on neural cells, muscle tissues and myeloma cells. Expression of CD56 has been studied in patients with multiple myeloma (MM) with controversial results. The scope of this study was to examine the expression of CD56 in...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pathology, research and practice research and practice, 2021-09, Vol.225, p.153567-153567, Article 153567
Hauptverfasser:	Koumpis, Epameinondas, Tassi, Iliana, Malea, Theodora, Papathanasiou, Konstantina, Papakonstantinou, Ioannis, Serpanou, Anastasia, Tsolas, Evangelos, Kapsali, Eleni, Vassilakopoulos, Theodoros P., Papoudou-Bai, Alexandra, Hatzimichael, Eleftheria
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Bone Marrow Cells - metabolism Bone Marrow Cells - pathology CD56 CD56 Antigen - metabolism Female Humans Male Middle Aged Multiple myeloma Multiple Myeloma - metabolism Multiple Myeloma - mortality Multiple Myeloma - pathology NCAM Prognosis Prognostic factor Retrospective Studies Survival Rate
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!